Exact Mass: 372.169851
Exact Mass Matches: 372.169851
Found 122 metabolites which its exact mass value is equals to given mass value 372.169851,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Buthiobate
butyl p-tert-butylbenzyl 3-pyridylimidodithiocarbonate
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007096 - Imidoesters
Diamfenetide
N-{4-[2-(2-{4-[(1-hydroxyethylidene)amino]phenoxy}ethoxy)ethoxy]phenyl}ethanimidic acid
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent
Medroxalol
5-(2-((3-(1,3-Benzodioxol-5-yl)-1-methylpropyl)amino)-1-hydroxyethyl)-2-hydroxybenzamide
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Pyroglutamyl-phenylalanyl-prolinamide
5-Hydroxy-N-{1-[2-(C-hydroxycarbonimidoyl)pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl}-3,4-dihydro-2H-pyrrole-2-carboximidate
MEDROXALOL
5-[2-[[3-(1,3-benzodioxol-5-yl)-1-methylpropyl]amino]-1-hydroxyethyl]salicylamide
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
2,4-Di-Me ether,1-O-beta-D-glucopyranoside-6-(1-Methylpropyl)-1,2,4-benzenetriol
2,4-Di-Me ether,1-O-beta-D-glucopyranoside-6-(1-Methylpropyl)-1,2,4-benzenetriol
2,6-dimethyl-3-hydroxymethyl-5-oxo-1,6-heptadiene-9-O-(6-acetyl-beta-D-glucopyranoside)
2,6-dimethyl-3-hydroxymethyl-5-oxo-1,6-heptadiene-9-O-(6-acetyl-beta-D-glucopyranoside)
4-hydroxy-2-(3-hydroxy-3-methylbutyl)-5-methylphenyl beta-D-glucopyranoside|4-Hydroxy-2-[3-hydroxy-3-methylbutyl]-5-methylphenyl ??-D-glucopyranoside
4-hydroxy-2-(3-hydroxy-3-methylbutyl)-5-methylphenyl beta-D-glucopyranoside|4-Hydroxy-2-[3-hydroxy-3-methylbutyl]-5-methylphenyl ??-D-glucopyranoside
(3S)-3-hydroxysedanolide beta-D-glucopyranoside|celephthalide C
(3S)-3-hydroxysedanolide beta-D-glucopyranoside|celephthalide C
5,5,6-Trimethyl-6-(1,2,3-triacetoxy-butyl)-tetrahydro-pyran-2-on|5,5,6-trimethyl-6-(1,2,3-triacetoxy-butyl)-tetrahydro-pyran-2-one
5,5,6-Trimethyl-6-(1,2,3-triacetoxy-butyl)-tetrahydro-pyran-2-on|5,5,6-trimethyl-6-(1,2,3-triacetoxy-butyl)-tetrahydro-pyran-2-one
5-(6-hydroxyhexyl)benzene-1,3-diol 1-O-beta-D-glucopyranoside|5-(6-hydroxyhexyl)resorcinol 1-O-beta-D-glucopyranoside|grevilloside H
5-(6-hydroxyhexyl)benzene-1,3-diol 1-O-beta-D-glucopyranoside|5-(6-hydroxyhexyl)resorcinol 1-O-beta-D-glucopyranoside|grevilloside H
1-Aldehyde,8-O-(2-acetyl-beta-D-glucopyranoside)-(E)-2-Methyl-6-methylene-2-octene-1,8-diol|7-Formyl-3-methylene-6E-octenol-O-beta-D-(2-O-acetylglucopyranoside)|7-Formyl-3-methylene-6E-octenol-O-beta-D-<2-O-acetylglucopyranoside>
1-Aldehyde,8-O-(2-acetyl-beta-D-glucopyranoside)-(E)-2-Methyl-6-methylene-2-octene-1,8-diol|7-Formyl-3-methylene-6E-octenol-O-beta-D-(2-O-acetylglucopyranoside)|7-Formyl-3-methylene-6E-octenol-O-beta-D-<2-O-acetylglucopyranoside>
DGR7D6J5TR
methyl (1R,12R,19S)-12-ethyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,9,13-pentaene-10-carboxylate;hydrochloride
C20H24N2O5_3-Pyridinecarboxylic acid, 1,4-dihydro-6-(hydroxyphenylmethyl)-1-[2-[(3-methyl-1-oxobutyl)amino]ethyl]-4-oxo
NCGC00380223-01_C20H24N2O5_3-Pyridinecarboxylic acid, 1,4-dihydro-6-(hydroxyphenylmethyl)-1-[2-[(3-methyl-1-oxobutyl)amino]ethyl]-4-oxo-
Ala Ala Asp Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid
Ala Ala Pro Asp
(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]propanoyl]pyrrolidin-2-yl]formamido}butanedioic acid
Ala Asp Ala Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]propanoyl]pyrrolidine-2-carboxylic acid
Ala Asp Pro Ala
(3S)-3-[(2S)-2-aminopropanamido]-4-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid
Ala Glu Gly Pro
(2S)-1-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carboxybutanamido]acetyl}pyrrolidine-2-carboxylic acid
Ala Glu Pro Gly
(4S)-4-[(2S)-2-aminopropanamido]-5-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid
Ala Gly Glu Pro
(2S)-1-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid
Ala Gly Pro Glu
(2S)-2-{[(2S)-1-{2-[(2S)-2-aminopropanamido]acetyl}pyrrolidin-2-yl]formamido}pentanedioic acid
Ala Pro Ala Asp
(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}propanamido]butanedioic acid
Ala Pro Asp Ala
(3S)-3-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid
Ala Pro Glu Gly
(4S)-4-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-4-[(carboxymethyl)carbamoyl]butanoic acid
Ala Pro Gly Glu
(2S)-2-(2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}acetamido)pentanedioic acid
Asp Ala Ala Pro
(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]propanoyl]pyrrolidine-2-carboxylic acid
Asp Ala Pro Ala
(3S)-3-amino-3-{[(2S)-1-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}propanoic acid
Asp Pro Ala Ala
(3S)-3-amino-4-[(2S)-2-{[(1S)-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid
Glu Ala Gly Pro
(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]propanamido]acetyl}pyrrolidine-2-carboxylic acid
Glu Ala Pro Gly
(4S)-4-amino-4-{[(2S)-1-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}butanoic acid
Glu Gly Ala Pro
(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-carboxybutanamido]acetamido}propanoyl]pyrrolidine-2-carboxylic acid
Glu Gly Pro Ala
(4S)-4-amino-4-({2-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-2-oxoethyl}carbamoyl)butanoic acid
Glu Pro Ala Gly
(4S)-4-amino-5-[(2S)-2-{[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid
Glu Pro Gly Ala
(4S)-4-amino-5-[(2S)-2-[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid
Gly Ala Glu Pro
(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid
Gly Ala Pro Glu
(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)propanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid
Gly Glu Ala Pro
(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carboxybutanamido]propanoyl]pyrrolidine-2-carboxylic acid
Gly Glu Pro Ala
(4S)-4-(2-aminoacetamido)-5-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid
Gly Pro Ala Glu
(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}propanamido]pentanedioic acid
Gly Pro Glu Ala
(4S)-4-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-{[(1S)-1-carboxyethyl]carbamoyl}butanoic acid
Pro Ala Ala Asp
(2S)-2-[(2S)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanedioic acid
Pro Ala Asp Ala
(3S)-3-{[(1S)-1-carboxyethyl]carbamoyl}-3-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanoic acid
Pro Ala Glu Gly
(4S)-4-[(carboxymethyl)carbamoyl]-4-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanoic acid
Pro Ala Gly Glu
(2S)-2-{2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}pentanedioic acid
Pro Asp Ala Ala
(3S)-3-{[(1S)-1-{[(1S)-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid
Pro Glu Ala Gly
(4S)-4-{[(1S)-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid
Pro Glu Gly Ala
(4S)-4-[({[(1S)-1-carboxyethyl]carbamoyl}methyl)carbamoyl]-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid
Pro Gly Ala Glu
(2S)-2-[(2S)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]pentanedioic acid
Pro Gly Glu Ala
(4S)-4-{[(1S)-1-carboxyethyl]carbamoyl}-4-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanoic acid
1-PYRROLIDIN-2-(2-CHLOROPHENYL)-2-(N-CBZ-N-METHYL)AMINO-ETHANE
1-PYRROLIDIN-2-(2-CHLOROPHENYL)-2-(N-CBZ-N-METHYL)AMINO-ETHANE
1-PYRROLIDIN-2-(3-CHLOROPHENYL)-2-(N-CBZ-N-METHYL)AMINO-ETHANE
1-PYRROLIDIN-2-(3-CHLOROPHENYL)-2-(N-CBZ-N-METHYL)AMINO-ETHANE
benzoic acid,2,2-dimethylpropane-1,3-diol,hexanedioic acid
benzoic acid,2,2-dimethylpropane-1,3-diol,hexanedioic acid
3H-Indolium,2-[2-[(2,4-dimethoxyphenyl)amino]ethenyl]-1,3,3-trimethyl-, chloride (1:1)
3H-Indolium,2-[2-[(2,4-dimethoxyphenyl)amino]ethenyl]-1,3,3-trimethyl-, chloride (1:1)
1-Decyl-3-Methylimidazolium Triflate
1-Decyl-3-Methylimidazolium Triflate
C15H27F3N2O3S (372.16943879999997)
(9H-FLUOREN-9-YL)METHYL ((1R,4R)-4-AMINOCYCLOHEXYL)CARBAMATE HYDROCHLORIDE
(9H-FLUOREN-9-YL)METHYL ((1R,4R)-4-AMINOCYCLOHEXYL)CARBAMATE HYDROCHLORIDE
ly 272015 hydrochloride
ly 272015 hydrochloride
LY-272015 hydrochloride is an orally active, specific 5-HT2B receptor antagonist. LY-272015 hydrochloride completely inhibits the phosphorylation of ERK2 induced by 5-HT or BW723C86. LY-272015 hydrochloride is antihypertensive in Deoxycorticosterone Acetate (DOCA)-salt-hypertensive rats[1][2].
N,N-(Methylene-p-phenylene)-bis-[N-(2-hydroxyethyl)]urea
N,N-(Methylene-p-phenylene)-bis-[N-(2-hydroxyethyl)]urea
N-[(1R)-1-Hydroperoxy-3-methylbutyl]-Nα-(2-pyrazinylcarbonyl)-L-phenylalaninamide
N-[(1R)-1-Hydroperoxy-3-methylbutyl]-Nα-(2-pyrazinylcarbonyl)-L-phenylalaninamide
N-[(1S)-1-Hydroperoxy-3-methylbutyl]-Nα-(2-pyrazinylcarbonyl)-L-phenylalaninamide
N-[(1S)-1-Hydroperoxy-3-methylbutyl]-Nα-(2-pyrazinylcarbonyl)-L-phenylalaninamide
(9H-Fluoren-9-yl)methyl 4-(aminomethyl)piperidine-1-carboxylate hydrochloride
(9H-Fluoren-9-yl)methyl 4-(aminomethyl)piperidine-1-carboxylate hydrochloride
N-Acetyl-leucyl-phenylalanyl trifluoromethyl ketone
N-Acetyl-leucyl-phenylalanyl trifluoromethyl ketone
2-[[1-Oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]-5-isoquinolinyl]oxy]acetic acid ethyl ester
2-[[1-Oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]-5-isoquinolinyl]oxy]acetic acid ethyl ester
4-[[(3,4-Dimethoxyanilino)-oxomethyl]amino]benzoic acid butyl ester
4-[[(3,4-Dimethoxyanilino)-oxomethyl]amino]benzoic acid butyl ester
4-[[(4-tert-butylphenyl)-oxomethyl]hydrazo]-N-(5-methyl-3-isoxazolyl)-4-oxobutanamide
4-[[(4-tert-butylphenyl)-oxomethyl]hydrazo]-N-(5-methyl-3-isoxazolyl)-4-oxobutanamide
3-Methyl-7-pentyl-8-(2-phenylethylthio)purine-2,6-dione
3-Methyl-7-pentyl-8-(2-phenylethylthio)purine-2,6-dione
N-[2-(3-ethoxypropylamino)-1-(4-methoxyphenyl)-2-oxoethyl]-2-pyrazinecarboxamide
N-[2-(3-ethoxypropylamino)-1-(4-methoxyphenyl)-2-oxoethyl]-2-pyrazinecarboxamide
17beta-(Acetylthio)estra-1,3,5(10)-trien-3-ol acetate
17beta-(Acetylthio)estra-1,3,5(10)-trien-3-ol acetate
(3S)-3-(Tert-butyldimethylsilyloxy)-5-tosylpentanol
(3S)-3-(Tert-butyldimethylsilyloxy)-5-tosylpentanol
CBL0137 (hydrochloride)
CBL0137 (hydrochloride)
CBL0137 hydrochloride is an inhibitor of the histone chaperone, FACT. CBL0137 hydrochloride can also activate p53 and inhibits NF-κB with EC50s of 0.37 and 0.47 μM, respectively.
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2r)-5-methyl-4-oxo-2-(prop-1-en-2-yl)hex-5-en-1-yl]oxy}oxan-2-yl]methyl acetate
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2r)-5-methyl-4-oxo-2-(prop-1-en-2-yl)hex-5-en-1-yl]oxy}oxan-2-yl]methyl acetate
3-[3-hydroxy-1-methoxy-1-(2-methylpropyl)-6-oxo-4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid
3-[3-hydroxy-1-methoxy-1-(2-methylpropyl)-6-oxo-4h-pyrazino[2,1-b]quinazolin-4-yl]propanimidic acid
n-{6-[hydroxy(phenyl)methyl]-1-(2-hydroxyethyl)-4-oxopyridine-3-carbonyl}-3-methylbutanimidic acid
n-{6-[hydroxy(phenyl)methyl]-1-(2-hydroxyethyl)-4-oxopyridine-3-carbonyl}-3-methylbutanimidic acid